Onconova Therapeutics
ONTX
#9918
Rank
โ‚ฌ20.4 M
Marketcap
0,97 โ‚ฌ
Share price
-0.47%
Change (1 day)
-4.34%
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2024 (TTM): โ‚ฌ0.2 Million

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.22 Million. In 2023 the company made a revenue of โ‚ฌ0.2 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2024

2013201620192022โ‚ฌ10Mโ‚ฌ20Mโ‚ฌ30Mโ‚ฌ40Mcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.2 M2.13%
2023 โ‚ฌ0.2 M-2.97%
2022 โ‚ฌ0.21 M5.58%
2021 โ‚ฌ0.19 M6.26%
2020 โ‚ฌ0.18 M-90.36%
2019 โ‚ฌ1.94 M81.54%
2018 โ‚ฌ1.07 M63.65%
2017 โ‚ฌ0.65 M-87.56%
2016 โ‚ฌ5.27 M-49.68%
2015 โ‚ฌ10.47 M1492.84%
2014 โ‚ฌ0.65 M-80.89%
2013 โ‚ฌ3.44 M-90.14%
2012 โ‚ฌ34.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ25.1 M 11,284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.95 B 434,497.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.65 B 6,189,280.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ73.94 M 33,426.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.61 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA